Summary
Three reparative strategies based on transfer of genes, molecules, or cells to the central nervous system are reviewed. When neurons are already lost, they can sometimes be replaced by transfer to the target area of neurons or other cells compensating for the lost functions. This technique is undergoing clinical trials in Parkinson’s disease. Before neurons have died, it may be possible to prevent “stressed” neurons from dying, and stimulate nerve terminal ramifications from remaining neurons using treatment with neurotrophic factors. Such approaches, with an emphasis on the NGF family of neurotrophins and their receptors, are reviewed. Finally, advances of molecular biology techniques suggest that it should be possible to transfer genes directly into non-dividing cells of the central nervous system. The three different approaches all aim at long-lasting counteractive and reparative measures in the central nervous system. It is predicted that they have general applicability, and may become important not only in neurodegenerative diseases, but also in other common afflictions of the nervous system such as ischaemia, stroke and injury.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barde YA (1990) The nerve growth factor family. Prog Growth Factor Res 2: 237–248
Bothwell M (1991) Keeping track of neurotrophin receptors. Cell 65: 915–918
David S, Aguayo AJ (1981) Axonal elongation into peripheral nervous system “bridges” after central nervous system injury in adult rats. Science 214: 931–93
Ebendal T (1992) Function and evolution in the NGF family and its receptors. J Neurosci Res 32: 461–470
Ernfors P, Ebendal T, Olson L, Mouton P, Strömberg I, Persson H (1989) A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons. Proc Natl Acad Sci USA 86: 4756–4760
Freed CR, Breeze RE, Roxenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, Ramig LO, Thompson L, Mazziotta JC, Huang SC, Grafton ST, Brooks D, Sawle G, Schroter G, Ansari AA (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N Engl J Med 327: 1549–1555
Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk R (1991) Antitransferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 88: 4771–4775
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341: 149–152
Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154–1162
Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leenders KL, Rothwell JC, Frackowiak R, Marsden CD, Johnels B, Steg G, Freedman R, Hoffer BJ, Seiger A, Bygdeman M, Strömberg I, Olson L (1989) Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 46: 615–631
Backlund E-O, Granberg PO, Hamberger B, Knutsson E, Märtensson A, Sedvall G, Seiger A, Olson L (1985) Transplantation of adrenal medullary tissue to striatum in Parkinsonism. First clinical trials. J Neurosurg 62: 169–173
Olson L (1988) Grafting in the mammalian central nervous system: Basic science with clinical promise. In: Magistretti P (ed) Discussions in neurosciences. FESN, Geneva, pp 1–73
Olson L, Backlund E-O, Ebendal T, Freedman R, Hamberger B, Hansson P, Hoffer B, Lindblom U, Meyerson B, Strömberg I, Sydow O, Seiger A (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease: One-year follow-up of first clinical trial. Arch Neurol 48: 373–381
Olson L, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, Lundqvist H, Längström B, Meyerson B, Persson A, Viitanen M, Winblad B, Seiger A (1992) Nerve growth factor affects “C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm (Park Dis Dement Sect) 4: 79–95
Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FH (1988) Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242: 1575–1578
Spencer, DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, Sass KJ, Elsworth JD, Kier EL, Makuch R, Hoffer PB, Redmond Jr DE (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med 327: 1541–1548
Strömberg I, Wetmore CJ, Ebendal T, Ernfors P, Persson H, Olson L (1990) Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J Neurosci Res 25: 405–411
Thoenen H (1991) The changing scene of neurotrophic factors. Trends Neurosci 14: 165–170
Wetmore C (1992) Brain-derived neurotrophic factor: Studies on the cellular localization and regulation of BDNF, related neurotrophins and their receptors at the mRNA and protein level. Ph.D. Thesis. Karolinska Institutet, Stockholm
Wetmore C, Cao Y, Pettersson RF, Olson L (1991) Brain-derived neurotrophic factor: Subcellular compartmentalization and interneuronal transfer as visualized with antipeptide antibodies. Proc Natl Acad Sci USA 88: 9843–9847
Wetmore C, Bean AJ, Olson L (1992) Regulation of cortical BDNF expression by non-NMDA glutamate receptors (manuscript )
Wetmore C, Cao Y, Pettersson RF, Olson L (1993) Brain-derived neurotrophic factor ( BDNF) peptide antibodies: Characterization using a vaccinia virus expression system. J Histochem Cytochem 41: 521–534
Widner H, Tetrud J, Rehncrona St, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW. Bilateral foetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327: 1556–1563
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Wien
About this paper
Cite this paper
Olson, L. (1993). Reparative Strategies in the Brain: Treatment Strategies Based on Trophic Factors and Cell Transfer Techniques. In: Meyerson, B.A., Broggi, G., Martin-Rodriguez, J., Ostertag, C., Sindou, M. (eds) Advances in Stereotactic and Functional Neurosurgery 10. Acta Neurochirurgica, vol 58. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9297-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9297-9_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-9299-3
Online ISBN: 978-3-7091-9297-9
eBook Packages: Springer Book Archive